Takeda Hid 'Dangerously Defective' Gout Drug's Risks
Takeda Pharmaceuticals USA Inc. failed to warn doctors and patients about the risks of taking its "dangerously defective" prescription drug Uloric to treat gout, a man who claims he suffered a...To view the full article, register now.
Already a subscriber? Click here to view full article